logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5662.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5662.produseast1
Showing 1 - 3 of 3 Items
Showing 1 - 3 of 3 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Clinical Presentation and Treatment Outcome of Sleeping Sickness in Sudanese Pre-School Children

Eperon G, Schmid C, Loutan L, Chappuis F
2007-01-01 • Acta Tropica
2007-01-01 • Acta Tropica
BACKGROUND: Existing data on human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense among children are limited. Here, we described the demographic, clinical, diagnostic,...
Journal Article
|
Research

Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II)

Schmid C, Richer M, Bilenge CM, Josenando T, Chappuis F,  et al.
2005-06-01 • Journal of Infectious Diseases
2005-06-01 • Journal of Infectious Diseases
BACKGROUND: Treatment of late-stage human African trypanosomiasis (HAT) with melarsoprol can be improved by shortening the regimen. A previous trial demonstrated the safety and efficacy ...
Journal Article
|
Research

In-hospital safety in field conditions of Nifurtimox Eflornithine Combination Therapy (NECT) for T. B. Gambiense Sleeping Sickness

Schmid C, Kuemmerle A, Blum J, Ghabri S, Kande V,  et al.
2012-11-29 • PLOS Neglected Tropical Diseases
2012-11-29 • PLOS Neglected Tropical Diseases
Trypanosoma brucei (T.b.) gambiense Human African trypanosomiasis (HAT; sleeping sickness) is a fatal disease. Until 2009, available treatments for 2(nd) stage HAT were complicated to us...